Comprehensive Analysis for Clinically Relevant Oncogenic Driver Mutations in 1131 Consecutive Lung Adenocarcinomas

被引：0
|
作者：
Arcila, M. E. [1 ]
Lau, C. [1 ]
Jhanwar, S. [1 ]
Zakowski, M. F. [1 ]
Kris, M. G. [1 ]
Ladanyi, M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1721
引用
收藏
页码：404A / 404A
页数：1
相关论文
共 50 条
  • [21] Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
    Oezkan, Filiz
    Herold, Thomas
    Darwiche, Kaid
    Eberhard, Wilfried E. E.
    Worm, Karl
    Christoph, Daniel C.
    Wiesweg, Marcel
    Freitag, Lutz
    Schmid, Kurt-Werner
    Theegarten, Dirk
    Hager, Thomas
    Koenig, Michael J.
    He, Kai
    Taube, Christian
    Schuler, Martin
    Breitenbuecher, Frank
    CLINICAL LUNG CANCER, 2018, 19 (06) : E879 - E884
  • [22] Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland
    Alexandra Grosse
    Claudia Grosse
    Markus Rechsteiner
    Alex Soltermann
    Diagnostic Pathology, 14
  • [23] Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland
    Grosse, Alexandra
    Grosse, Claudia
    Rechsteiner, Markus
    Soltermann, Alex
    DIAGNOSTIC PATHOLOGY, 2019, 14 (1)
  • [24] Analysis of CDK4/6 Pathway Activity in Lung Adenocarcinoma Patients with Oncogenic Driver Mutations in China
    Yu, Y.
    Lu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S812 - S813
  • [25] Lung adenocarcinomas subtyping is not relevant for EGFR mutations, gene copy number and protein expression
    Carvalho, L.
    Alarcao, A.
    Couceiro, P.
    Silva, M. Reis
    D'Aguiar, M. J.
    Teixeira, L.
    Ferreira, T.
    Sousa, V.
    VIRCHOWS ARCHIV, 2011, 459 : S321 - S321
  • [26] ONCOGENIC DRIVER MUTATIONS IN CHINESE NON-SMALL CELL LUNG CANCER (NSCLC)
    He, J.
    Yang, H.
    Deng, Q.
    He, P.
    Jiang, J.
    Zhao, M.
    Gu, X.
    Zheng, L.
    Pang, H.
    Zhou, J. X.
    ANNALS OF ONCOLOGY, 2012, 23 : 389 - 390
  • [27] Lung cancer pathogenesis and poor response to therapy were dependent on driver oncogenic mutations
    Sun, Xin
    Li, Kai
    Zhao, Rui
    Sun, Ye
    Xu, Jie
    Peng, Zi-Yang
    Song, Run-Dong
    Ren, Hong
    Tang, Shou-Ching
    LIFE SCIENCES, 2021, 265
  • [28] Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers
    Xiang, Libing
    Li, Jiajia
    Jiang, Wei
    Shen, Xuxia
    Yang, Wentao
    Wu, Xiaohua
    Yang, Huijuan
    ONCOTARGET, 2015, 6 (07) : 4968 - 4975
  • [29] EGFR and KRAS Mutations in 3026 Consecutive Lung Adenocarcinomas Associations with Age Sex and Smoking History
    Dogan, S.
    Ang, D. C.
    Brzostowski, E.
    Johnson, M. L.
    DAngelo, S. P.
    Paik, P.
    Riely, G. J.
    Zakowski, M. F.
    Ladanyi, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 908 - 909
  • [30] ANALYSES OF MUTUALLY EXCLUSIVE DRIVER MUTATIONS IN LUNG ADENOCARCINOMAS FROM NEVER-SMOKING PATIENTS
    Suda, Kenichi
    Tomizawa, Kenji
    Matsuo, Keitaro
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S511 - S511
12345